Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potent LT biosynthesis inhibitors described by Abbott

June 6, 1997

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

June 4, 1997

PPL Therapeutics reports positive phase I results for AAT

June 3, 1997

Antiallergic/antiasthmatic agents from Sumitomo Metal

June 2, 1997

T Cell Sciences completes patient enrollment for reperfusion injury trial

June 2, 1997

Positive preclinical results for Inflazyme's Apanol

June 2, 1997

U.K. introduction for Nasonex

May 29, 1997

Selective M3 antagonists from Banyu

May 29, 1997

FLAP inhibitor from Bayer inhibits allergen-induced bronchoconstriction in atopic asthmatics

May 28, 1997

Chiroscience discloses cytokine inhibitors

May 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...